FDA Inspection
Sarah Cannon Blood And Marrow Transplant Program Cell ProcesSarah Cannon Blood And Marrow Transplant Program Cell Proces – FDA Inspection, Jul 23, 2010
Record Details
This FDA Inspection record concerns Sarah Cannon Blood And Marrow Transplant Program Cell Proces, with an inspection on July 23, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 23, 2010
- Product Type
- Biologics
View Company Profile
ID · 796b749c-64c2-4762-bd89-9780b569f2b4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 673050
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.200(e)Documentation of maintenance and cleaning
- 21 CFR 1271.170(b)Not qualified, authorized for functions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sarah Cannon Blood And Marrow Transplant Program Cell Proces
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 25, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Sarah Cannon Blood And Marrow Transplant Program Cell Proces
- FDA Inspection 916051 - 2015-02-27
- FDA Inspection 663729 - 2010-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.